(Q45262234)

11 December 2017

title

Consequences of genetic polymorphisms for sirolimus requirements after renal transplant in patients on primary sirolimus therapy (English)

1 reference

11 December 2017

1 reference

4

1 reference

11 December 2017

6

1 reference

11 December 2017

Dany Anglicheau

1

1 reference

11 December 2017

Delphine Le Corre

2

1 reference

11 December 2017

Sophie Lechaton

3

1 reference

11 December 2017

Henri Kreis

5

1 reference

11 December 2017

Christophe Legendre

7

1 reference

11 December 2017

Eric Thervet

8

1 reference

11 December 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

American Journal of Transplantation

11 December 2017

published in

1 reference

11 December 2017

volume

5

1 reference

11 December 2017

issue

3

1 reference

11 December 2017

page(s)

595-603

1 reference

Therapeutic drug monitoring of sirolimus: correlations with efficacy and toxicity

11 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

Pharmacogenomics: translating functional genomics into rational therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

The role of individual human cytochromes P450 in drug metabolism and clinical response

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

Cyclosporine and liver transplantation: will the midazolam test make blood level monitoring obsolete?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

Genetic contribution to variable human CYP3A-mediated metabolism

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

In vitro and in situ absorption of SDZ-RAD using a human intestinal cell line (Caco-2) and a single pass perfusion model in rats: comparison with rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

Biochemical, cellular, and pharmacological aspects of the multidrug transporter

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

Polymorphisms in human MDR1 (P-glycoprotein): recent advances and clinical relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

Genetic polymorphisms of the CYP3A4, CYP3A5, and MDR-1 genes and pharmacokinetics of the calcineurin inhibitors cyclosporine and tacrolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

Impact of cytochrome p450 3A5 genetic polymorphism on tacrolimus doses and concentration-to-dose ratio in renal transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

The effect of CYP3A5 and MDR1 (ABCB1) polymorphisms on cyclosporine and tacrolimus dose requirements and trough blood levels in stable renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

Tacrolimus Dosing in Pediatric Heart Transplant Patients is Related to CYP3A5 and MDR1 Gene Polymorphisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

CYP3A5 and MDR1 genetic polymorphisms and cyclosporine pharmacokinetics after renal transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

Association of the multidrug resistance-1 gene single-nucleotide polymorphisms with the tacrolimus dose requirements in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

Identification of functionally variant MDR1 alleles among European Americans and African Americans

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

Therapeutic drug monitoring of sirolimus: effect of concomitant immunosuppressive therapy and optimization of drug dosing

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

Metabolic interaction between cyclosporine and sirolimus

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

Long-term safety of hepatic hydroxymethyl glutaryl coenzyme A reductase inhibitors: the role of metabolism-monograph for physicians

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

Multidrug resistance transporters and modulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

Frequency of cytochrome P450 3A4 variant genotype in transplant population and lack of association with cyclosporin clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

Modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

RESPONSE: re: modification of clinical presentation of prostate tumors by a novel genetic variant in CYP3A4

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

Tacrolimus pharmacogenetics: polymorphisms associated with expression of cytochrome p4503A5 and P-glycoprotein correlate with dose requirement

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

Genetic polymorphisms in MDR1 and CYP3A4 genes in Asians and the influence of MDR1 haplotypes on cyclosporin disposition in heart transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

The effect of CYP3A5 and MDR1 polymorphic expression on cyclosporine oral disposition in renal transplant patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1600-6143.2005.00745.X

10.1111/J.1600-6143.2005.00745.X

21 January 2018

Identifiers

DOI

1 reference

11 December 2017

1 reference